A new platform for studying neuroinflammatory diseases, utilizing advanced 3D bioprinting technology has been developed.

The discovery and development of GLP-1 receptor agonists for type 2 diabetes and obesity is a bench-to-bedside success story.1 Multiple GLP-1 receptor agonists are now in clinical use, such as ...

Conversations about Medicine and Writing  on Jan. 31. The first speaker was Dr. Lakshmi Krishnan, a historian of medicine, ...

The Centre’s purpose is to unlock solutions within capital markets to address the challenges posed by global climate change. We execute interdisciplinary research combining intellectual rigour and ...